BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 22173046)

  • 1. Normocalcemic primary hyperparathyroidism-characteristics and clinical significance of an emerging entity.
    Shlapack MA; Rizvi AA; Lopez FA
    Am J Med Sci; 2012 Feb; 343(2):163-166. PubMed ID: 22173046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Normal ionized serum calcium is a prerequisite for characterization of normocalcemic primary hyperparathyroidism.
    Jolobe OM
    Am J Med Sci; 2012 Jun; 343(6):512. PubMed ID: 22683617
    [No Abstract]   [Full Text] [Related]  

  • 3. Normocalcemic Primary Hyperparathyroidism: A Comparison with the Hypercalcemic Form in a Tertiary Referral Population.
    Pierreux J; Bravenboer B
    Horm Metab Res; 2018 Nov; 50(11):797-802. PubMed ID: 30396209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IDENTIFYING PARATHYROID HORMONE DISORDERS AND THEIR PHENOTYPES THROUGH A BONE HEALTH SCREENING PANEL: IT'S NOT SIMPLE VITAMIN D DEFICIENCY!
    Majid H; Khan AH; Riaz M; Karimi H; Talati J
    Endocr Pract; 2016 Jul; 22(7):814-21. PubMed ID: 27018622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Normocalcemic primary hyperparathyroidism: a growing problem].
    Martínez Díaz-Guerra G; Guadalix Iglesias S; Hawkins Carranza F
    Med Clin (Barc); 2013 Aug; 141(3):125-9. PubMed ID: 23199831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of primary hyperparathyroidism among patients with low bone mass.
    Misiorowski W; Zgliczyński W
    Adv Med Sci; 2012; 57(2):308-13. PubMed ID: 23314564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin D status, seasonal variations, parathyroid adenoma weight and bone mineral density in primary hyperparathyroidism.
    Moosgaard B; Vestergaard P; Heickendorff L; Melsen F; Christiansen P; Mosekilde L
    Clin Endocrinol (Oxf); 2005 Nov; 63(5):506-13. PubMed ID: 16268801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary hyperparathyroidism.
    Silva BC; Cusano NE; Bilezikian JP
    Best Pract Res Clin Endocrinol Metab; 2018 Oct; 32(5):593-607. PubMed ID: 30449543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary Hyperparathyroidism: Effects on Bone Health.
    Zanocco KA; Yeh MW
    Endocrinol Metab Clin North Am; 2017 Mar; 46(1):87-104. PubMed ID: 28131138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Normocalcemic primary hyperparathyroidism].
    Spivacow FR; Sapag Durán A; Zanchetta MB
    Medicina (B Aires); 2014; 74(6):457-61. PubMed ID: 25555006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Normocalcemic primary hyperparathyroidism: recommendations for management and follow-up].
    Martínez Díaz-Guerra G; Jódar Gimeno E; Reyes García R; Gómez Sáez JM; Muñoz-Torres M;
    Endocrinol Nutr; 2013 Oct; 60(8):456.e1-6. PubMed ID: 23660008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation and Management of Elevated Parathyroid Hormone Levels in Normocalcemic Patients.
    Cusano NE
    Med Clin North Am; 2021 Nov; 105(6):1135-1150. PubMed ID: 34688419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Normocalcemic primary hyperparathyroidism.
    Cusano NE; Cetani F
    Arch Endocrinol Metab; 2022 Nov; 66(5):666-677. PubMed ID: 36382756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary Hyperparathyroidism.
    Bilezikian JP
    J Clin Endocrinol Metab; 2018 Nov; 103(11):3993-4004. PubMed ID: 30060226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An overview of normocalcemic primary hyperparathyroidism.
    Pawlowska M; Cusano NE
    Curr Opin Endocrinol Diabetes Obes; 2015 Dec; 22(6):413-21. PubMed ID: 26512768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Normocalcemic primary hyperparathyroidism: a newly emerging disease needing therapeutic intervention.
    Díaz-Soto G; Julián MT; Puig-Domingo M
    Hormones (Athens); 2012; 11(4):390-6. PubMed ID: 23422761
    [No Abstract]   [Full Text] [Related]  

  • 17. Normocalcemic primary hyperparathyroidism.
    Cusano NE; Silverberg SJ; Bilezikian JP
    J Clin Densitom; 2013; 16(1):33-9. PubMed ID: 23374739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The phenotype of primary hyperparathyroidism with normal parathyroid hormone levels: how low can parathyroid hormone go?
    Wallace LB; Parikh RT; Ross LV; Mazzaglia PJ; Foley C; Shin JJ; Mitchell JC; Berber E; Siperstein AE; Milas M
    Surgery; 2011 Dec; 150(6):1102-12. PubMed ID: 22136828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin D deficiency and primary hyperparathyroidism.
    Silverberg SJ
    J Bone Miner Res; 2007 Dec; 22 Suppl 2():V100-4. PubMed ID: 18290710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of skeletal health in patients with asymptomatic primary hyperparathyroidism.
    Lewiecki EM
    J Clin Densitom; 2010; 13(4):324-34. PubMed ID: 21029971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.